BLI Banque de Luxembourg Investments Acquires New Stake in UnitedHealth Group Incorporated (NYSE:UNH)

BLI Banque de Luxembourg Investments bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the fourth quarter, Holdings Channel.com reports. The fund bought 107,210 shares of the healthcare conglomerate’s stock, valued at approximately $54,485,000. UnitedHealth Group accounts for 1.5% of BLI Banque de Luxembourg Investments’ portfolio, making the stock its 20th largest position.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in UNH. Sugarloaf Wealth Management LLC increased its holdings in UnitedHealth Group by 17.6% during the 4th quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock worth $4,025,000 after purchasing an additional 1,193 shares during the period. Signal Advisors Wealth LLC raised its holdings in shares of UnitedHealth Group by 13.0% in the fourth quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock valued at $4,611,000 after acquiring an additional 1,051 shares in the last quarter. Waycross Partners LLC grew its holdings in UnitedHealth Group by 2.4% during the 4th quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate’s stock worth $14,060,000 after acquiring an additional 658 shares in the last quarter. Czech National Bank raised its holdings in shares of UnitedHealth Group by 6.1% in the 4th quarter. Czech National Bank now owns 199,536 shares of the healthcare conglomerate’s stock valued at $100,937,000 after purchasing an additional 11,426 shares in the last quarter. Finally, Lmcg Investments LLC increased its holdings in UnitedHealth Group by 11.8% during the fourth quarter. Lmcg Investments LLC now owns 37,974 shares of the healthcare conglomerate’s stock valued at $19,210,000 after buying an additional 4,022 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 0.5 %

UnitedHealth Group stock opened at $398.72 on Friday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 52 week low of $393.11 and a 52 week high of $630.73. The business’s 50-day moving average price is $495.85 and its 200 day moving average price is $528.45. The firm has a market cap of $362.92 billion, a price-to-earnings ratio of 25.72, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same quarter in the prior year, the business posted $6.91 EPS. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.11%. UnitedHealth Group’s dividend payout ratio (DPR) is 35.18%.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on UNH shares. Raymond James reiterated a “strong-buy” rating and issued a $540.00 price target (down from $635.00) on shares of UnitedHealth Group in a report on Monday, April 21st. Hsbc Global Res lowered shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, April 22nd. Cantor Fitzgerald reiterated an “overweight” rating and set a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Truist Financial cut their price target on shares of UnitedHealth Group from $660.00 to $580.00 and set a “buy” rating on the stock in a report on Monday, April 21st. Finally, Royal Bank of Canada lowered their price objective on UnitedHealth Group from $655.00 to $525.00 and set an “outperform” rating for the company in a research report on Wednesday, April 23rd. Four investment analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $596.86.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.